Skip to main content
eScholarship
Open Access Publications from the University of California

Relationships between the Nicotine Metabolite Ratio and a Panel of Exposure and Effect Biomarkers: Findings from Two Studies of U.S. Commercial Cigarette Smokers.

  • Author(s): Carroll, Dana M
  • Murphy, Sharon E
  • Benowitz, Neal L
  • Strasser, Andrew A
  • Kotlyar, Michael
  • Hecht, Stephen S
  • Carmella, Steve G
  • McClernon, Francis J
  • Pacek, Lauren R
  • Dermody, Sarah S
  • Vandrey, Ryan G
  • Donny, Eric C
  • Hatsukami, Dorothy K
  • et al.

Published Web Location

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437528/pdf/nihms-1555324.pdf
No data is associated with this publication.
Creative Commons 'BY-NC-SA' version 4.0 license
Abstract

Background

We examined the nicotine metabolite ratio's (NMR) relationship with smoking intensity, nicotine dependence, and a broad array of biomarkers of exposure and biological effect in commercial cigarette smokers.

Methods

Secondary analysis was conducted on two cross-sectional samples of adult, daily smokers from Wave 1 (2013-2014) of the Population Assessment of Tobacco Use and Health (PATH) Study and baseline data from a 2014-2017 randomized clinical trial. Data were restricted to participants of non-Hispanic, white race. The lowest quartile of NMR (<0.26) in the nationally representative PATH Study was used to distinguish slow from normal/fast nicotine metabolizers. NMR was modeled continuously in secondary analysis.

Results

Compared with slow metabolizers, normal/fast metabolizers had greater cigarettes per day and higher levels of total nicotine equivalents, tobacco-specific nitrosamines, volatile organic componds, and polycyclic aromatic hydrocarbons. A novel finding was higher levels of inflammatory biomarkers among normal/fast metabolizers versus slow metabolizers. With NMR modeled as a continuous measure, the associations between NMR and biomarkers of inflammation were not significant.

Conclusions

The results are suggestive that normal/fast nicotine metabolizers may be at increased risk for tobacco-related disease due to being heavier smokers, having higher exposure to numerous toxicants and carcinogens, and having higher levels of inflammation when compared with slow metabolizers.

Impact

This is the first documentation that NMR is not only associated with smoking exposure but also biomarkers of biological effects that are integral in the development of tobacco-related disease. Results provide support for NMR as a biomarker for understanding a smoker's exposure and potential risk for tobacco-related disease.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item